Insurance Coverage for Psychedelic Therapy
Bill of Health
MARCH 27, 2024
By Vincent Joralemon As therapies using drugs like MDMA, psilocybin, and LSD advance through the FDA research and approval pipeline, patients should be prepared for steep price tags attached to these procedures. Although this may be highly cost-effective (considering the cost of untreated PTSD), insurers may balk at the price tag.
201 
Let's personalize your content